A 2019 systematic review (87) identified three placebo-controlled interventions that examined the effect of oral supplementation with acetyl-L-carnitine (ALCAR
A total of 3286 patients had taken a GLP-1 RA and 1692 had taken an SGLT2i at some point in time
KEY FINDINGS Average weight loss on treatment: 7.9 kg (all GLP-1s) 16.1 kg (newer GLP-1s like semaglutide/tirzepatide) Weight regained after stopping: 0.70.8 kg/month 8.39.6 kg regained in the first year Full return to baseline: 0.9 years (older GLP-1s) 1.7 years (newer GLP-1s) Bottom line: GLP-1s are effective, but without ongoing treatment or structured long-term care, the benefits fade quickly
Check the due-today amount, cancellation window, refund policy, renewal date, and what happens if you stop treatment before the term ends
For these reasons, dietary modifications are often more effective than medications at reducing GLP-1-related gas during the first month of therapy
Please note: The service is intended for patients with a confirmed vitamin B12 deficiency diagnosis or those that have been previously prescribed a vitamin B12 injection